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Abstract
Background: Advances in techniques have left very few indications for open surgical extraction of urinary stones
currently. These advances notwithstanding, the search continues for medical approaches to urinary stone
management. In this study, we perform an in vitro study analyzing the efficiency and prospect of two new complex
solutions in urological calcium phosphate calculi dissolution.
Methods: Eighteen stones composed mainly of calcium phosphates were taken from patients who underwent
kidney stone surgery. These stones were large enough (weight range 0.514–0.928 g) to be fragmented and
matched equally into six groups. Chemolysis of phosphate stones was done with six different solvents and was
repeated 3 times with 6 stones for each solution. At 24, 48 and 72 h, reduction in weight, percentage weight
change, and dissolution rate; the dissolution rates at pH 5.0, 7.0 and 8.5 for each solution, using different cations
(Na+, K+ or Ca2+), according to different dilutions (1:1, 1:2, 1:3, 1:4) of S1 and S2 were simultaneously determined.
Results: Calcium phosphate calculi were poorly dissolved by Phys and Art, and they had a low dissolution rate
in pH 8.5 EDTA. The most effective solutions were S1, S2 and R, with 72 h mean dissolution rates: 5.75 ± 0.44
mg/hr (S1), 5.2 ± 0.63 mg/hr (S2), 4.55 ± 0.46 mg/hr (R) (  ± s, p < 0.01 R, S1 and S2 vs Phys, Art and EDTA; p
< 0.05, S1 vs R, LSD-test). The mean percentage weight loss at 72 h was: 52.1 ± 15.75 % (S1), 44.4 ± 7.37 % (S2)
and 40.5 ± 3.67 % (R) (  ± s, p < 0.01 R, S1 and S2 vs Phys, Art and EDTA, LSD-test). Diluted twice, S1 and S2
had even better effectiveness than their initial solution. The additive of Na+, K+ or Ca2+ greatly reduced the
dissolution rates of S1, S2.
Conclusion: Our data indicate that test solutions S1 and S2 are effective solvents in the chemolysis of calcium
phosphate stones. At twice dilutions, these solutions are even more useful in the treatment of stone disease.
Background
The most important phosphate-containing calculi
involved in urinary stone disease are carbonate apatite,
brushite, and struvite. Overall, phosphate stones account
for 12–20% of all urinary stones and rank first in the list
of recurrent calculi [1]. The most definitive therapy
involving any type of phosphate stone is calculus removal
by shock-wave lithotripsy, percutaneous stone removal,
or open surgery (especially in children). However, while
technologies have successfully treated patients with
Published: 22 May 2005
BMC Urology 2005, 5:9 doi:10.1186/1471-2490-5-9
Received: 06 December 2004
Accepted: 22 May 2005
This article is available from: http://www.biomedcentral.com/1471-2490/5/9
© 2005 Xiang-bo et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
x
xBMC Urology 2005, 5:9 http://www.biomedcentral.com/1471-2490/5/9
Page 2 of 6
(page number not for citation purposes)
phosphate calculi, they are associated with injury to the
urinary tissue and retained stone fragments have resulted
in recurrences.
Stone dissolution through chemolysis remains an option
for urologists even in the advent of more sophisticated
modalities in the treatment of urolithiasis. Chemolysis via
acidification of the urine and antibiotic therapy (espe-
cially for infection stones) are important adjuvant modal-
ities for phosphate calculi therapy. Hitherto, a many
solutions have been tested in the quest for more effective
dissolution agents. The most effective solution among
them is Renacidin (R), which is a buffer consisting mainly
of citrate and gluconate [2-4]. These solutions are deliv-
ered directly into the kidney by ureteric catheter or percu-
taneous nephrostomy, and are successful in the
dissolution of struvite. But the injury to urothelium
restrains their wide use. So, solutions with more dissolu-
tion efficiency and less side effects are needed urgently
and may be used widely. Our in vitro study was designed
to evaluate the effectiveness of two new complex solutions
(using D-gluconic acid-lactone, D-gluconic-acid and
other ingredients which makes them different from R) in
the chemolysis of calcium phosphate stones.
Material and methods
Stones specimen preparation
Eighteen stones composed mainly of calcium phosphate
were taken from 18 patients who underwent kidney stone
surgery. These stones were large enough (weight range
from 0.514–0.928 g) to be fragmented and matched
equally into six groups. Each stone was analyzed using the
Merckognost at Urinary Stone analysis Kit. The chemical
composition of these stones was varied but there was a
predominance of calcium phosphate in almost all the
stones and calcium oxalate was less than 10% (Table 1,
Table 2).
Preparation of solvent
Six different solvents were used for chemolysis of phos-
phate stones. The molecular formula and the molecular
weights of some drugs used in these solvents are provided
in Table 3.
Table 1: Chemical analysis of 18 stones for stone dissolution. There was a predominance of calcium phosphate in almost all the stones 
and calcium oxalate was less than 10%.
Stone% Ca Oxalate NH4 PO4 Mg Uric Acid Tri-calcium 
phosphate
Calcium 
oxalate
Struvite
1 . 4 5 225 7 7
2. 60 45 10 9
3. 60 10 4 55 10
4. 45 15 45 5 4
5. 35 5 35
6. 80 11 3 65 6
7. 50 10 60 6
8 . 4 0 272 5 5 7
9. 5 5 45 15 20 8
1 0 . 1 52 0 1 54 0 6
1 1 . 4 5 534 5 1 0
1 2 . 3 52 02 3 5
1 3 . 5 02 05 2 5
14. 40 10 35 15
15. 45 15 35 9
1 6 . 4 01 50 . 5 3 5 5
17. 75 5 15
18. 15 5 45 10 15
Table 2: Mean chemical composition of 18 stones, showing that 
there was a predominance of calcium phosphate in almost all the 
stones and calcium oxalate was less than 10%.
Composition  ± s (%)
Ca++ 42.5 ± 20.7
Oxalate 9.6 ± 6.2
NH4 1.5 ± 2.1
PO4 40.1 ± 13.9
Mg 1.7 ± 4.9
Uric acid 3.3 ± 4.9
Cystine 0.0 ± 0.0
Ca++oxalate 3.4 ± 3.7
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1. Physiologic sodium chloride solution (Phys).
2. Artificial urine (Art, pH5.7, according to Griffith et al
[5]) consisting of urea (25 g/L), sodium chloride (4.6 g/
L), potassium-dihydrogen-phosphate (2.8 g/L), sodium
sulfate (2.3 g/L), potassium chloride (1.6 g/L), ammo-
nium chloride (1.0 g/L), calcium chloride dehydrate (0.1
g/L), sodium oxalate (0.05 g/L), and sodium citrate (0.01
g/L), dissolved in 1000 ml. distilled water.
3. 0.03 M disodium ethylenediaminetetraacetic acid buff-
ered to pH 8.5 with triethanolamine (EDTA, pH 8.5)
4. 10% Renacidin (R, pH 3.9), consisting of citric acid
(28.2 g), gluconic acid (5.0 g), calcium carbonate (1.0 g),
magnesium bicarbonate (14.5 g), citrate magnesium (2.5
g), dissolved in 1000 ml. distilled water.
5. Test solution 2 (S2, pH 4.0), prepared using citric acid
(18.0 g), citrate magnesium (1.0 g), calcium carbonate
(0.5 g), magnesium carbonate (7.5 g), D-gluconic acid-
lactone (3.0 g), dissolved in 100 ml. distilled water. The
solution was kept at 37? for 3 days, then diluted with 140
ml. distilled water. The concentrations of these ingredi-
ents are shown in Table 4.
6. Test solution 1 (S1, pH 3.9), prepared using citric acid
(18.0 g), citrate magnesium (1.0 g), calcium carbonate
(0.5 g), magnesium carbonate (7.5 g), D-gluconic-acid
(3.0 g), dissolved in 100 ml. distilled water, and processed
as described for S2. The concentrations of these ingredi-
ents are shown in Table 4).
We also altered the pH of these solutions to 4, 5, 7, and
8.5 to test their effectiveness and added different cations
(Na+, by adding 302.7 mmol/L citrate sodium 10 ml. into
100 ml. of the initial solution; K+, by adding 302.7 mmol/
L citrate potassium 10 ml. into 100 ml. of the initial solu-
tion; Ca2+, by adding 454.5 mmol/L calcium chloride
anhydrous 10 ml. into 100 ml. of the initial solution). S1
and S2 were formulated according to different dilutions
(1:1, 1:2, 1:3, 1:4). The pH of these changed solutions had
no detectable variation. After stones were immersed in
these solvents for 24, 48 and 72 h, reduction in weight,
percentage weight loss, and dissolution rate were deter-
mined. Results were analyzed using the Multiple Compar-
isons Test with the alpha set at 0.05. Stones remaining
after the dissolution period were weighed (gm), and final
weights were applied to the following formula:
The formula used to determine the dissolution rate was:
Chemolysis
Every stone was placed in a vessel containing solvents,
which were held at a constant temperature of 37? using a
thermostat. Solvents were exchanged 2 times per day at 6
ml/100 mg per stone each time. The pH values were
Table 3: Molecular formulae and molecular weights of chemical drugs used in our experiment
Experimental drug Molecular formula Molecular weight
Citric acid C6H6O7·H2O 210.14
Sodium citrate Na3 C6H6O7·2H2O 294.11
D-Gluconic Acid Lactone C6H10O6 178.1
Magnesium citrate Mg3(C6H5O7)2·14H2O 703.4
Magnesium Carbonate (MgCO3)4·Mg(OH)2·5H2O 485.8
Disodium EDTA C10H14O8N2Na2·2H2O 372.24
Potassium citrate, tribasic K3C6H5O7·H2O 324.34
Potassium phosphate, monobasic KH2PO4 136.09
Table 4: Concentrations of chemical drugs contained in S1 and 
S2
Chemical drug Concentration (mmol/L)
Citric acid 357.1
Magnesium citrate 5.9
Magnesium Carbonate 64.3
D-Gluconic Acid Lactone 70.2
Calcium carbonate 20.8
D-Gluconic Acid 63.8
Sodium citrate 302.7
Potassium citrate, tribasic 302.7
Calcium chloride, anhydrous 454.5
Calcium carbonate is difficult to be dissolved in water, but in acidic 
solutions of S1 or S2, it can be dissolved thoroughly. So we give the 
concentration of Calcium as above. In diluted solutions these cations 
were diluted correspondingly, such that their pH did not change.
%Stone weight loss
(Initial weight Final weight)
(Initial w
=
−
e eight)
× 100
Dissolution rate
Initial weight (gm) Final weight (gm)
Time
=
−
   (hrs)
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constantly controlled by a pH meter (Mettler Toledo 320-
S, sensitivity 0.01). The weight of the calculus was meas-
ured continuously by Electronic Semi-micro-, Analytical
and Precision Balances (Sartorius BP211D-OCE, sensitiv-
ity 0.01 mg) and documented online with a computer sys-
tem (PC windows 486, Software Wedge for window,
version 1.1). The analysis represents six stones for each
experiment, repeated three independent times.
Results
Urological calcium phosphate calculi were poorly dis-
solved by Phys and Art, and they had a low dissolution
rate in EDTA at pH 8.5. The most effective solutions were
R, S1 and S2 with 24 h mean dissolution rates: 5.05 ± 0.15
mg/hr (S1), 4.52 ± 0.64 mg/hr (S2), 4.53 ± 0.46 mg/hr
(R); 72 h mean dissolution rates: 5.75 ± 0.44 mg/hr (S1),
5.2 ± 0.63 mg/hr (S2) and 4.55 ± 0.46 mg/hr (R) (  ± s,
P < 0.01, R, S1 and S2 vs Phys, Art and EDTA; P < 0.05, S1
vs R, LSD-test). The mean percentage weight loss at 72 h
was: 40.5 ± 3.67 % (R), 52.1 ± 15.75 % (S1) and 44.4 ±
7.37 % (S2) (  ± s, p < 0.01 R, S1 and S2 vs Phys, Art and
EDTA, LSD-test). Figure 1 shows the average dissolution
rates of the 6 different solutions at the end of 72 h.
Table 5 Shows mean weight loss and mean percentage
weight loss of stones dissolved by the 6 solutions at the
end of 24 and 72 h. (  ± s, aP < 0.01 Phys, Art and EDTA
vs R, S1 and S2; bP < 0.05 EDTA vs S1, S2 and R.cP < 0.05
R vs S1).
The dissolution rates were pH dependent. Even Phys and
Art were effective to some extent at pH 4. The addition of
1 mol/L sodium hydroxide 10 ml into S1 or S2 100 ml,
though not enough to lead to a detectable pH rise, would
make the solutions cloudy and greatly reduce their effec-
tiveness. At pH 5.0 they were nearly ineffective, as also
observed at pH 7.0, 8.5. However, the dissolution rate of
EDTA increased at an elevated pH value. At pH 8.5, EDTA
approached a maximum dissolution rate with 72 h mean
1.56 ± 0.05 mg/hr (Figure 2).
The addition of Na+, K+ or Ca2+ (302.7 mmol/L Sodium
citrate 10 ml, 302.7 mmol /L Potassium citrate 10 ml or
454.5 mmol/L Calcium chloride dihydrate 10 ml into
Table 5: Mean weight and percentage weight decrease after 24 and 72 h between groups dissolved with 6 different solutions. Phys = 
physiologic sodium chloride solution, pH 7.0. Art = artificial urine, pH 5.7. EDTA = 0.03 M disodium EDTA+TEA, pH 8.5. R = renacidin, 
pH 4.0. S1 = citrate complex 1, pH 4.0. S2 = citrate complex 2, pH 3.9.   ± s, aP < 0.01 vs R, S1 and S2.bP < 0.05 vs S1, S2.cP < 0.05 vs 
S1. n = 18 for each group. For statistics, see results section.
Groups Weight loss (mg) Percentage weight loss (%)
2 4  h7 2  h2 4  h7 2  h
Phys 3.52 ± 0.73a 18.15 ± 13.15a 0.00 ± 0.00a 1.33 ± 1.53a
Art 2.48 ± 0.37a 7.44 ± 1.9a 0.00 ± 0.00a 0.00 ± 0.00a
EDTA 43.78 ± 6.23ab 153.6 ± 20.84ab 4.67 ± 2.08ab 19.00 ± 5.19ab
R 114.4 ± 8.92c 346.14 ± 26.56c 13 ± 1.35c 40.5 ± 3.67c
S2 127 ± 23.09 408.11 ± 62.94 13.5 ± 2.76 44.4 ± 7.37
S1 138.5 ± 31.09 439.5 ± 102.00 5.77 ± 1.29 52.1 ± 15.75
x
Dissolution rates of phosphate calculi in vitro at 24 and 72 h  using different solutions Figure 1
Dissolution rates of phosphate calculi in vitro at 24 
and 72 h using different solutions. Phys = physiologic 
sodium chloride solution, pH 7.0. Art = artificial urine, pH 
5.7. EDTA = 0.03 M disodium EDTA+TEA, pH 8.5. R = rena-
cidin, pH 4.0. S1 = test solution 1, pH 4.0. S2 = test solution 
2, pH 3.9. aP < 0.01 vs Phys and Art. bP > 0.05 vs EDTA, Phys 
and Art. cP < 0.05 vs R·  ± s·n = 18 for each group. For sta-
tistics, see results section.
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initial solution 100 ml, respectively) caused no significant
change in dissolution rate.
Diluted solutions demonstrated an interesting result.
Diluted twice, S1 and S2 were more effective than their
initial solutions with 72 h mean dissolution rates: 6.04 ±
1.36 mg/hr (S1), 5.60 ± 1.23 mg/hr (S2) (  ± s, P < 0.05,
S1 and S2 vs R). The effectiveness of three times diluted S1
or S2 was the same as the initial solution. When diluted
further, the effectiveness was reduced gradually until
nearly 0 after solutions were diluted five times (Figure 3).
Discussion
Chemolysis is useful for eliminating cystine stones as well
as for cases in which lithotripsy or endourology is consid-
ered to be difficult or risky. It proved to be a useful
method for reducing staghorn stones before performing
lithotripsy [6]. The type of chemolytic solution is depend-
ent upon the composition of the stone and must be
regarded as an effective adjuvant treatment [7]. Calcium
phosphate can be dissolved with Suby or R, but the treat-
ment is often tedious and time consuming. Calcium
oxalate, the major urinary stone component, cannot be
dissolved by these solutions. EDTA and other strong cal-
cium chelators cannot be used because of their local tox-
icity. Certain enzymes can digest the organic matrix of the
stone [8]. The first attempts to dissolve calcium stones
were done by Hellstrom and Albright in 1930. They used
citric acid for phosphate calculi, but this proved irritating
to tissues. Suby and Albright modified the solution by
adding magnesium oxide and sodium carbonate (Suby's
G solution) [9,10] to reduce injury to the rabbit bladder
mucosa even though adding this cation reduced the speed
of dissolution of struvite Mg (NH4) PO4. A contradictory
conclusion was been made by a Dutch study [11] that
magnesium in R promotes stone dissolution by cation
exchange with calcium in apatite [12].
Our S1 and S2 solutions were similar to R although actual
formulas were different. First, we added D-gluconic acid-
lactone or D-gluconic-acid as new chelators which bind
with calcium well by their special trait. Second, we used
new ingredients and ingredients at different weights. The
higher density of our solutions than R may be one of the
factors which enhanced stone dissolution rates, but it may
prevented further dissolution. When diluted twice, the
solutions may have gained more space to accommodate
cations than the initial solutions and achieve better effec-
tiveness (P < 0.05, S1 and S2 vs R). The further diluted
solutions had a lower concentration suggesting that less
ingredient took part in the reaction thus accounting for a
lower dissolution rate. So, we think twice diluted S1 and
S2 may be more useful than their initial solutions.
The dissolution of the majority of the stones in this study
can be attributed on the basis of their reaction equation:
3Ca+2 + 2 Citrate→ CaCitrate→ Ca2+ + CaCitrate
Effectiveness of six solvents at different pH (mg/hr) Figure 2
Effectiveness of six solvents at different pH (mg/hr). 
Phys = physiologic sodium chloride solution, Art = artificial 
urine, EDTA = 0.03 M disodium EDTA+TEA, R = renacidin, 
S1 = test solution 1, S2 = test solution 2.
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Concentration and effective of S1 and S2 Figure 3
Concentration and effective of S1 and S2
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The citrate in the solution binds with the calcium compo-
nent of the stone producing calcium citrate, thus prevent-
ing crystallization. The dissolution process may be
brought about by the combination of the above reaction.
As the solubility of calcium phosphate is very pH depend-
ent, the acidification of the urine by the incorporation of
citric acid produce a pH between 3.0–4.0, the ideal pH for
dissolution as described by Albright et al [9,10]. When the
pH is elevated, the citrate will react with cations thus los-
ing its effectiveness. On the other hand, excessive alkaliza-
tion may lead to the formation of calcium phosphate
calculi. Added minor quantities of cations (Na+, K+ or
Ca2+) in S1 and S2 apparently causes no significant
change to their dissolution rate.
Conclusion
The study has shown that solutions S1 and S2 can dissolve
calcium phosphate stones effectively in vitro at a precise
dilution of their chemical components. Based on these
findings, it is suggested that S1 and S2 may become useful
complements to modern techniques of stone fragmenta-
tion such as extracorporeal shock wave lithotripsy and
percutaneous surgery. Their roles may be suited for the
treatment of infectious stones with a CaOx content of less
than 10%. However, their safety profiles should be further
investigated in order to support their use in subsequent
human trials.
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